Table 4.
Person-years | Cases | IRR (95% CI)a | |
---|---|---|---|
History of UL, any age | |||
In situ breast cancer | |||
No UL | 491,368 | 184 | 1.00 (Ref.) |
UL at any age | 368,295 | 210 | 1.02 (0.82-1.27) |
Stage 1 breast cancer | |||
No UL | 491,561 | 337 | 1.00 (Ref.) |
UL at any age | 368,513 | 376 | 0.99 (0.84-1.16) |
Stage 2, 3 or 4 breast cancer | |||
No UL | 491,665 | 430 | 1.00 (Ref.) |
UL at any age | 368,519 | 396 | 0.97 (0.83-1.12) |
History of UL, age<30 years | |||
In situ breast cancer | |||
No UL | 491,368 | 184 | 1.00 (Ref.) |
UL at age<30 | 88,302 | 45 | 1.04 (0.72-1.49) |
Stage 1 breast cancer | |||
No UL | 491,561 | 337 | 1.00 (Ref.) |
UL at age<30 | 88,350 | 87 | 1.16 (0.90-1.50) |
Stage 2, 3, or 4 breast cancer | |||
No UL | 491,665 | 430 | 1.00 (Ref.) |
UL at age<30 | 88,377 | 105 | 1.16 (0.92-1.47) |
Adjusted for age, questionnaire cycle, menopausal status, cause of menopause, age at menopause, parity, age at first birth, years since last birth, BMI, age at menarche, female hormone use (recency and formulation), smoking, alcohol consumption, family history of breast cancer, education, and vigorous exercise.
There were 160 invasive cases (80 exposed and 80 unexposed) with missing data on stage at diagnosis.